About: http://data.cimple.eu/news-article/1b183a93de9034078d51660f2ac912ee74dd5e85d41fe9e2ac3d90e6

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/1b183a93de9034078d51660f2ac912ee74dd5e85d41fe9e2ac3d90e6 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	Venezuela's government on Thursday announced it had signed a contract to acquire 12 million doses of a Cuban coronavirus vaccine that is allegedly 92 percent effective but is still awaiting approval from health authorities. The Abdala vaccine has completed its three phases of clinical trials but has yet to be given the all-clear either by Cuba's health authorities or the World Health Organization. "We are grateful that this vaccine will be incorporated into Venezuela's immunization program and we've signed a contract for the supply of 12 million Abdala vaccine that we will receive over the coming months," Venezuela's Vice-President Delcy Rodriguez said. Rodriguez was on hand at Maiquetia international airport just outside Caracas to receive the first batch of doses alongside Cuba's ambassador to Caracas, Dagoberto Rodriguez. "Millions more doses will arrive," said the Venezuelan official, without specifying how many were in the first batch. Cuba's state pharmaceutical company BioCubaFarma announced on Monday that the Abdala vaccine was over 92 percent effective against the coronavirus. If approved it will be the first coronavirus vaccine created and produced in Latin America. Cuba has also developed another vaccine called Soberana 2 and last week said it was 62 percent effective after two doses, although authorities envisage three will be needed for all vaccines made on the island nation. In April, Venezuelan President Nicolas Maduro announced the country would produce two million doses per month of the Abdala vaccine in August and September. Venezuela hopes to immunize 70 percent of its population of 30 million this year and has previously acquired the Russian Sputnik V and Chinese Sinopharm vaccines. Authorities have come under fire for the country's slow vaccine rollout, which it blames on US economic sanctions but which the opposition says is due to incompetence. mbj/jt/bc/dw
schema:headline	Venezuela announces acquisition of 12 million Cuban vaccine doses
schema:mentions	Latin America Delcy Rodríguez Deutsche Welle Immunization USA Gymnastics Caracas Pharmaceutical industry Sputnik 1 Economic sanctions Chinese language Nicolás Maduro Cuba World Health Organization Venezuela Russian language Vaccine Severe acute respiratory syndrome coronavirus 2 Dagoberto Simón Bolívar International Airport (Venezuela) President of Venezuela China National Pharmaceutical Group
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2021-06-24 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	neutral sentiment
http://data.cimple...readability_score	87 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 5 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software